naproxen has been researched along with hydrogen sulfide in 22 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (hydrogen sulfide) | Trials (hydrogen sulfide) | Recent Studies (post-2010) (hydrogen sulfide) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 8,039 | 83 | 5,149 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (4.55) | 29.6817 |
2010's | 18 (81.82) | 24.3611 |
2020's | 3 (13.64) | 2.80 |
Authors | Studies |
---|---|
Distrutti, E; Fiorucci, S; Santucci, L | 1 |
Caliendo, G; Cirino, G; Santagada, V; Wallace, JL | 1 |
Boring, D; Chattopadhyay, M; Dastagirzada, YM; Kashfi, K; Kodela, R; Nath, N; Velázquez-Martínez, CA | 1 |
Ferraz, JG; Flannigan, KL; McKnight, W; Tuitt, D; Wallace, JL; Wang, L | 1 |
Ahmad, A; Campolo, M; Cuzzocrea, S; Di Paola, R; Esposito, E; Wallace, JL | 1 |
Atkinson, TJ; Fudin, J; Jahn, HL; Kubotera, N; Rennick, AL; Rhorer, M | 1 |
Biletska, L; Bondarchuk, T; Fomenko, I; Panasyuk, N; Sklyarov, A; Wallace, JL | 1 |
Bercik, P; Blackler, RW; Manko, A; Motta, JP; Surette, MG; Wallace, JL; Workentine, M | 1 |
Ahmad, A; Bruschetta, G; Campolo, M; Cordaro, M; Cuzzocrea, S; Di Paola, R; Esposito, E; Paterniti, I; Wallace, JL | 1 |
Bula, N; Gavrilyuk, E; Khyrivska, D; Wallace, JL; Zayachkivska, O | 1 |
Gemici, B; Wallace, JL | 1 |
Bercik, P; Blackler, RW; Buret, AG; Da Silva, GJ; De Palma, G; Flannigan, KL; Manko, A; Surette, MG; Wallace, JL | 1 |
Bula, N; Havryluk, E; Hrytsevych, N; Khyrivska, D; Pshyk-Titko, I; Savytska, M; Zayachkivska, O | 1 |
Dief, AE; Mostafa, DK; Sharara, GM; Zeitoun, TH | 1 |
Chattopadhyay, M; Kashfi, K; Kodela, R; Nath, N; Nesbitt, DE; Velázquez-Martínez, CA | 1 |
Agbor, TA; Chan, M; Cheadle, C; Devchand, P; Elsheikh, W; Flannigan, KL; Freydin, M; Ianaro, A; Kirkby, N; Mitchell, JA; Paul-Clark, M; Wallace, JL | 1 |
El Azhary, NM; Mostafa, DK; Nasra, RA | 1 |
de Nucci, G; Dicay, M; MacNaughton, WK; Vaughan, D; Wallace, JL | 1 |
Allain, T; Buret, AG; de Nucci, G; Ditrói, T; Feener, TD; Muscara, MN; Nagy, P; Vaughan, DJ; Wallace, JL | 1 |
Pluth, MD; Steiger, AK; Zhao, Y | 1 |
Flint, JD; Gilroy, DW; Glanville, JRW; Hosin, AA; Jalali, P; Maini, AA; Patel, AA; Wallace, JL | 1 |
Caliendo, G; Corvino, A; Esposito, G; Fiorino, F; Frecentese, F; Magli, E; Migliaccio, M; Perissutti, E; Santagada, V; Scognamiglio, A; Severino, B; Sparaco, R | 1 |
4 review(s) available for naproxen and hydrogen sulfide
Article | Year |
---|---|
NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Disease Models, Animal; Duodenal Ulcer; Gastric Mucosa; Humans; Hydrogen Sulfide; Naproxen; Nitric Oxide; Nitric Oxide Donors; Stomach Ulcer | 2007 |
What's new in NSAID pharmacotherapy: oral agents to injectables.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Humans; Hyaluronic Acid; Hydrogen Sulfide; Ibuprofen; Injections; Injections, Intra-Articular; Isoxazoles; Nanoparticles; Naproxen; Nitric Oxide Donors; Vasodilator Agents | 2013 |
Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic.
Topics: Animals; Arthritis; Captopril; Cardiovascular Agents; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Hydrogen Sulfide; Naproxen | 2018 |
H
Topics: Animals; Benzenesulfonates; Chemistry, Pharmaceutical; Drug Discovery; Gasotransmitters; Humans; Hydrogen Sulfide; Morpholines; Naproxen; Organothiophosphorus Compounds | 2021 |
2 trial(s) available for naproxen and hydrogen sulfide
Article | Year |
---|---|
A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Double-Blind Method; Humans; Hydrogen Sulfide; Naproxen; Pharmaceutical Preparations | 2020 |
Potent anti-inflammatory effects of an H
Topics: Adolescent; Adult; Dinoprostone; Escherichia coli; Humans; Hydrogen Sulfide; Inflammation; Male; Middle Aged; Monocytes; Naproxen; Neutrophils; Pain; Phenotype; Solubility; Ultraviolet Rays; Vasoconstriction; Young Adult | 2021 |
16 other study(ies) available for naproxen and hydrogen sulfide
Article | Year |
---|---|
Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Gastric Mucosa; Hydrogen Sulfide; Hypertension; Intestinal Mucosa; Intestine, Small; Male; Mice; Molecular Structure; Naproxen; Rats; Rats, Wistar; Stomach Ulcer | 2010 |
Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Cell Line, Tumor; Cell Proliferation; Growth Inhibitors; Humans; Hydrogen Sulfide; Ibuprofen; Naproxen; Sulindac; Thiones | 2012 |
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cannabis; Colitis; Gastrointestinal Tract; Hydrogen Sulfide; Indoles; Male; Naproxen; Piperidines; Plant Extracts; Protective Agents; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stomach Ulcer; Visceral Pain | 2013 |
A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury.
Topics: Administration, Oral; Animals; Apoptosis; Cyclooxygenase Inhibitors; Cytokines; Hydrogen Sulfide; Locomotion; Male; Mice; Naproxen; Recovery of Function; Spinal Cord; Spinal Cord Injuries | 2013 |
Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Celecoxib; Disease Models, Animal; Epinephrine; Gastric Mucosa; Hydrogen Sulfide; Lipid Peroxidation; Male; Naproxen; Nitric Oxide; Nitric Oxide Synthase; Pyrazoles; Rats, Wistar; Restraint, Physical; Severity of Illness Index; Stomach Ulcer; Stress, Psychological; Sulfonamides | 2014 |
Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota.
Topics: Alanine; Allyl Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bile; Cell Line; Cyclooxygenase 1; Gastrointestinal Hemorrhage; Humans; Hydrogen Sulfide; Intestinal Diseases; Intestinal Mucosa; Jejunum; Membrane Proteins; Microbiota; Naproxen; Protective Agents; Rats, Wistar; Sulfides; Ulcer | 2015 |
Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice.
Topics: Animals; Brain Injuries; Cerebral Cortex; Cyclooxygenase Inhibitors; Hydrogen Sulfide; Male; Mice; Motor Skills Disorders; Naproxen; Organ Size; Random Allocation | 2014 |
Exposure to non-steroid anti-inflammatory drugs (NSAIDs) and suppressing hydrogen sulfide synthesis leads to altered structure and impaired function of the oesophagus and oesophagogastric junction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Models, Animal; Esophagogastric Junction; Hydrogen Sulfide; Naproxen; Rats; Sulfides | 2015 |
Anti-inflammatory and cytoprotective properties of hydrogen sulfide.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Gastrointestinal Tract; Gene Expression Regulation; Humans; Hydrogen Sulfide; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Naproxen; Neurodegenerative Diseases; Pain; Protective Agents; Signal Transduction; Spinal Cord Injuries | 2015 |
Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Hepatobiliary Elimination; Hydrogen Sulfide; Inflammation; Intestinal Diseases; Male; Naproxen; Proton Pump Inhibitors; Rats, Wistar; RNA, Ribosomal, 16S | 2015 |
Effect of CCl4 and blocking H2S biosynthesis on oesophageal mucosa rats: model of nonerosive oesophagitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Tetrachloride; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Esophagitis, Peptic; Esophagus; Hydrogen Sulfide; Interleukin-10; Interleukin-17; Mucous Membrane; Naproxen; Nitric Oxide; Rats; Rats, Wistar | 2014 |
Hydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Hydrogen Sulfide; Injections, Intra-Articular; Male; Naproxen; Neutrophils; Pain; Rats; Rats, Wistar; Zymosan | 2015 |
Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; HT29 Cells; Humans; Hydrogen Sulfide; Male; Mice, Nude; Naproxen; NF-kappa B; Signal Transduction; Thioredoxin-Disulfide Reductase; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis.
Topics: Adenomatous Polyposis Coli Protein; Animals; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Carcinogenesis; Chemoprevention; Colon; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hydrogen Sulfide; Intestinal Neoplasms; Intestinal Polyps; Male; Mice; Mice, Inbred C57BL; Naproxen; Proto-Oncogene Proteins c-myc | 2016 |
The hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment, neuroinflammation, and oxidative stress in rats: involvement of asymmetric dimethylarginine.
Topics: Allyl Compounds; Animals; Arginine; Cognitive Dysfunction; Hydrogen Sulfide; Inflammation; Inflammation Mediators; Male; Maze Learning; Naproxen; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Sulfides | 2016 |
Cyclic Sulfenyl Thiocarbamates Release Carbonyl Sulfide and Hydrogen Sulfide Independently in Thiol-Promoted Pathways.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Carbonic Anhydrases; Cyclization; HeLa Cells; Humans; Hydrogen Sulfide; Naproxen; Sulfhydryl Compounds; Sulfur Oxides; Thiocarbamates | 2019 |